Evidence map›Paper›PMID 22115776›Full record

ArticleSchizophrenia bulletin2013

Schizophrenia candidate gene ERBB4: covert routes of vulnerability to psychosis detected at the population level.

Nicholas C Stefanis, Alex Hatzimanolis, Nikolaos Smyrnis, Dimitrios Avramopoulos, Ioannis Evdokimidis, Jim van Os, Costas N Stefanis, Richard E Straub, Daniel R Weinberger

Open access · bronzeAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Examining the Psychosis Continuum.Current behavioral neuroscience reports · 2015
    Article
  6. Article
  7. PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  8. Type III neuregulin 1 is required for multiple forms of excitatory synaptic plasticity of mouse cortico-amygdala circuits.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Nicholas C StefanisUniversity Mental Health Research Institute, Athens, Greece. nikos.stefanis@uwa.edu.au
Alex Hatzimanolis
Nikolaos Smyrnis
Dimitrios Avramopoulos
Ioannis Evdokimidis
Jim van Os
Costas N Stefanis
Richard E Straub
Daniel R Weinberger
University Mental Health Research Institute · GRNational and Kapodistrian University of Athens · GRNational Institutes of Health · USJohns Hopkins Medicine · USMaastricht University Medical Centre · NL

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Prior genetic and functional evidence established ERBB4 as a probable schizophrenia susceptibility gene that may confer risk via modulating brain information processing dependent on the integrity of frontotemporal brain circuitry. Utilizing retrospective data drawn from the cross-sectional population-based Athens Study of Psychosis Proneness and Incidence of Schizophrenia (ASPIS) (n = 1127), we attempted to independently replicate and further extend previous findings by examining the effects of ERBB4 gene variants on 3 broad population-based psychosis-related phenotypes: verbal working memory (VWM), trait schizotypy, and stress-induced subclinical psychotic experiences (PE). Three common ERBB4 single nucleotide polymorphisms that were previously associated with schizophrenia and impaired frontotemporal-related information processing (rs7598440, rs839523, and rs707284), their haplotypes, and corresponding diplotypes were tested. VWM performance was significantly associated with rs839523 and rs707284 markers even after correction for multiple testing, thus validating reported findings that have implicated ERBB4 gene variation on working memory. No associations were detected between these ERBB4 variants and trait schizotypy. However, we were able to detect a significant effect of rs7598440 marker on PE expressed under stressful environmental conditions. Combined haplotype analysis of the above 3 markers, identified a "yin-yang" pattern of association, confirmed at the diplotype level. While GGG haplotype homozygotes were associated with "protective" effects on VWM performance and PE, AAA "risk" haplotype carriers were associated with worse VWM performance and simultaneously exhibited significantly elevated PE. This dual, possibly pleiotropic, impact on frontotemporal circuitry and increased sensitivity to psychosocial stress may represent subtle manifestations of ERBB4-related vulnerability to psychosis, expressed at the population level.

Indexed as

AdolescentCross-Sectional StudiesErbB ReceptorsGenetic Predisposition to DiseaseGenotypeHaplotypesHumansMaleMemory DisordersMemory, Short-TermMilitary PersonnelPhenotypePolymorphism, Single NucleotidePsychotic DisordersReceptor, ErbB-4Retrospective StudiesERBB4 protein, humanErbB ReceptorsReceptor, ErbB-4

Identifiers

PMID22115776
PMCPMC3576167
OpenAlexW2148561535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.